Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD 416.48
+12.40 (3.07%)
At close: May 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Commercial & Specialty Business | - |
Log In |
Log In |
Log In |
Log In |
| Commercial & Specialty Business Growth | - |
Log In |
Log In |
Log In |
Log In |
| Government Business | - |
Log In |
Log In |
Log In |
Log In |
| Government Business Growth | - |
Log In |
Log In |
Log In |
Log In |
| Other | - |
Log In |
Log In |
Log In |
Log In |
| Other Growth | - |
Log In |
Log In |
Log In |
Log In |
| Health Benefits | 154.45B |
Log In |
Log In |
Log In |
Log In |
| Health Benefits Growth | 3.97% |
Log In |
Log In |
Log In |
Log In |
| CarelonRx | - |
Log In |
Log In |
Log In |
Log In |
| CarelonRx Growth | - |
Log In |
Log In |
Log In |
Log In |
| Total Carelon | 58.50B |
Log In |
Log In |
Log In |
Log In |
| Total Carelon Growth | 20.43% |
Log In |
Log In |
Log In |
Log In |
| Corporate & Other | 347.00M |
Log In |
Log In |
Log In |
Log In |
| Corporate & Other Growth | -32.62% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Commercial & Specialty Business Operating Income | - |
Log In |
Log In |
Log In |
Log In |
| Commercial & Specialty Business Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In |
| Government Business Operating Income | - |
Log In |
Log In |
Log In |
Log In |
| Government Business Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In |
| Other Operating Income | - |
Log In |
Log In |
Log In |
Log In |
| Other Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In |
| CarelonRx Operating Income | - |
Log In |
Log In |
Log In |
Log In |
| CarelonRx Operating Income Growth | - |
Log In |
Log In |
Log In |
Log In |
| Health Benefits Operating Income | 6.17B |
Log In |
Log In |
Log In |
Log In |
| Health Benefits Operating Income Growth | -12.30% |
Log In |
Log In |
Log In |
Log In |
| Total Carelon Operating Income | 3.17B |
Log In |
Log In |
Log In |
Log In |
| Total Carelon Operating Income Growth | 16.21% |
Log In |
Log In |
Log In |
Log In |
| Corporate & Other Operating Income | -1.33B |
Log In |
Log In |
Log In |
Log In |
| Corporate & Other Operating Income Growth | 24.04% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Total Medical Membership | 45.83M |
Log In |
Log In |
Log In |
Log In |
| Total Medical Membership Growth | -0.47% |
Log In |
Log In |
Log In |
Log In |